Cargando…

Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta

BACKGROUND: Optic neuritis is associated with neurodegeneration leading to chronic impairment of visual functions. OBJECTIVE: This study investigated whether early treatment with interferon beta (IFN-β) slows retinal nerve fibre layer (RNFL) thinning in clinically isolated optic neuritis. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Sühs, Kurt-Wolfram, Hein, Katharina, Pehlke, Jens R., Käsmann-Kellner, Barbara, Diem, Ricarda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521715/
https://www.ncbi.nlm.nih.gov/pubmed/23272128
http://dx.doi.org/10.1371/journal.pone.0051645
_version_ 1782252986949435392
author Sühs, Kurt-Wolfram
Hein, Katharina
Pehlke, Jens R.
Käsmann-Kellner, Barbara
Diem, Ricarda
author_facet Sühs, Kurt-Wolfram
Hein, Katharina
Pehlke, Jens R.
Käsmann-Kellner, Barbara
Diem, Ricarda
author_sort Sühs, Kurt-Wolfram
collection PubMed
description BACKGROUND: Optic neuritis is associated with neurodegeneration leading to chronic impairment of visual functions. OBJECTIVE: This study investigated whether early treatment with interferon beta (IFN-β) slows retinal nerve fibre layer (RNFL) thinning in clinically isolated optic neuritis. METHODS: Twenty patients with optic neuritis and visual acuity decreased to ≤0.5 (decimal system) were included into this prospective, open-label, parallel group 4-month observation. After methylprednisolone pulse therapy, 10 patients received IFN-β from week 2 onwards. This group was compared to 10 patients free of any disease modifying treatment (DMT). The parameter of interest was change in RNFL thickness assessed at baseline and at weeks 4, 8, and 16. Changes in visual acuity, visual field, and visual evoked potentials (VEPs) served as additional outcome parameters. RESULTS: RNFL thinning did not differ between the groups with a mean reduction of 9.80±2.80 µm in IFN-β-treated patients (±SD) vs. 12.44±5.79 µm in patients who did not receive DMT (baseline non-affected eye minus affected eye at week 16; p = 0.67, t-test, 95% confidence interval: −15.77 to 10.48). Parameters of visual function did not show any differences between the groups either. CONCLUSIONS: In isolated optic neuritis, early IFN-β treatment did not influence RNFL thinning nor had it any effect on recovery of visual functions.
format Online
Article
Text
id pubmed-3521715
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35217152012-12-27 Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta Sühs, Kurt-Wolfram Hein, Katharina Pehlke, Jens R. Käsmann-Kellner, Barbara Diem, Ricarda PLoS One Research Article BACKGROUND: Optic neuritis is associated with neurodegeneration leading to chronic impairment of visual functions. OBJECTIVE: This study investigated whether early treatment with interferon beta (IFN-β) slows retinal nerve fibre layer (RNFL) thinning in clinically isolated optic neuritis. METHODS: Twenty patients with optic neuritis and visual acuity decreased to ≤0.5 (decimal system) were included into this prospective, open-label, parallel group 4-month observation. After methylprednisolone pulse therapy, 10 patients received IFN-β from week 2 onwards. This group was compared to 10 patients free of any disease modifying treatment (DMT). The parameter of interest was change in RNFL thickness assessed at baseline and at weeks 4, 8, and 16. Changes in visual acuity, visual field, and visual evoked potentials (VEPs) served as additional outcome parameters. RESULTS: RNFL thinning did not differ between the groups with a mean reduction of 9.80±2.80 µm in IFN-β-treated patients (±SD) vs. 12.44±5.79 µm in patients who did not receive DMT (baseline non-affected eye minus affected eye at week 16; p = 0.67, t-test, 95% confidence interval: −15.77 to 10.48). Parameters of visual function did not show any differences between the groups either. CONCLUSIONS: In isolated optic neuritis, early IFN-β treatment did not influence RNFL thinning nor had it any effect on recovery of visual functions. Public Library of Science 2012-12-13 /pmc/articles/PMC3521715/ /pubmed/23272128 http://dx.doi.org/10.1371/journal.pone.0051645 Text en © 2012 Sühs et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sühs, Kurt-Wolfram
Hein, Katharina
Pehlke, Jens R.
Käsmann-Kellner, Barbara
Diem, Ricarda
Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta
title Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta
title_full Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta
title_fullStr Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta
title_full_unstemmed Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta
title_short Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta
title_sort retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-beta
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521715/
https://www.ncbi.nlm.nih.gov/pubmed/23272128
http://dx.doi.org/10.1371/journal.pone.0051645
work_keys_str_mv AT suhskurtwolfram retinalnervefibrelayerthinninginpatientswithclinicallyisolatedopticneuritisandearlytreatmentwithinterferonbeta
AT heinkatharina retinalnervefibrelayerthinninginpatientswithclinicallyisolatedopticneuritisandearlytreatmentwithinterferonbeta
AT pehlkejensr retinalnervefibrelayerthinninginpatientswithclinicallyisolatedopticneuritisandearlytreatmentwithinterferonbeta
AT kasmannkellnerbarbara retinalnervefibrelayerthinninginpatientswithclinicallyisolatedopticneuritisandearlytreatmentwithinterferonbeta
AT diemricarda retinalnervefibrelayerthinninginpatientswithclinicallyisolatedopticneuritisandearlytreatmentwithinterferonbeta